Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
POET: Efficacy of 11-Valent Pneumococcal Vaccine for AOM
NCT00119743Phase 3Terminated
- Sponsor
- GSK
- Start
- Oct 2000
- Primary completion
- Jun 2004
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 2
01
Overview
A Phase 3 trial of Undecavalent pneumococcal-protein D conjugate vaccine in acute otitis media (AOM), sponsored by GSK. Started Oct 2000; status: terminated.
02
Drugs
Undecavalent pneumococcal-protein D conjugate vaccine
03
Conditions
acute otitis media (AOM)
Beyond the preview
Go deeper on NCT00119743.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00119743.